Targeted Cell Therapies Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

Targeted Cell Therapies General Information

Description

Dveeloper of a novel delivery technology designed for unmet needs in the oral delivery of large molecule drugs. The company addresses needs in the oral delivery of large molecule drugs for a broad range of disease conditions and has the potential to eliminate the need for either viral and lipid vectors or costly and difficult-to-manufacture injectables in disease treatment, enabling patients with easily ingestible drugs that are of lower cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • 60 Prescott Street
  • Worcester, MA 01605
  • United States
+1 (508) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Targeted Cell Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jan-2023 00000 Completed Generating Revenue
3. Accelerator/Incubator 00000 Completed Generating Revenue
2. Angel (individual) 31-Oct-2013 $500K Completed Generating Revenue
1. Seed Round 06-Dec-2007 $500K $500K Completed Generating Revenue
To view Targeted Cell Therapies’s complete valuation and funding history, request access »

Targeted Cell Therapies Executive Team (4)

Name Title Board Seat
Edward Ginns Ph.D Interim Chief Executive Officer and President
Siddarth Rathi MD Chief Strategy Officer
Gilbert Addo Jr. Chief Business Development Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Targeted Cell Therapies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Targeted Cell Therapies FAQs

  • When was Targeted Cell Therapies founded?

    Targeted Cell Therapies was founded in 2006.

  • Who is the founder of Targeted Cell Therapies?

    Edward Ginns Ph.D and Eric Evans are the founders of Targeted Cell Therapies.

  • Who is the CEO of Targeted Cell Therapies?

    Edward Ginns Ph.D is the CEO of Targeted Cell Therapies.

  • Where is Targeted Cell Therapies headquartered?

    Targeted Cell Therapies is headquartered in Worcester, MA.

  • What is the size of Targeted Cell Therapies?

    Targeted Cell Therapies has 4 total employees.

  • What industry is Targeted Cell Therapies in?

    Targeted Cell Therapies’s primary industry is Drug Delivery.

  • Is Targeted Cell Therapies a private or public company?

    Targeted Cell Therapies is a Private company.

  • What is Targeted Cell Therapies’s current revenue?

    The current revenue for Targeted Cell Therapies is 000000.

  • How much funding has Targeted Cell Therapies raised over time?

    Targeted Cell Therapies has raised $500K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »